HOME >> BIOLOGY >> NEWS
UT Southwestern biochemist honored with NIH Director's Pioneer Award

DALLAS Sept. 29, 2004 Dr. Steven McKnight, chairman of biochemistry at UT Southwestern Medical Center at Dallas, is the recipient of a National Institutes of Health Director's Pioneer Award, a new initiative designed to support exceptionally creative investigators.

The award, $500,000 per year for five years, is in its inaugural year and aims at encouraging investigators to take on creative, unexplored avenues of research that carry a relatively high potential for failure, but that also possess a greater chance for truly groundbreaking discoveries. It is one component of the NIH Roadmap for Medical Research, which provides a framework of the NIH's priorities in identifying the most compelling opportunities in medical research.

Dr. McKnight the only winner from Texas is one of nine researchers in America to receive the new award. His research involves the regulation of transcription factors, the proteins that switch genes on and off.

"There is nothing about science that captivates me more than the sheer joy of adventure," said Dr. McKnight, who holds the Sam G. Winstead and F. Andrew Bell Distinguished Chair in Biochemistry and the Distinguished Chair in Basic Biomedical Research. "To be judged by my peers as a pioneer is the highest accolade I could possibly imagine receiving. I'm on cloud nine to hear that I was selected to receive one of the inaugural Pioneer Awards from the National Institutes of Health."

One of the most significant turns Dr. McKnight took in his career was to move from his early work on transcription factors to the study of gene regulation in the brain. One of his current projects has led to the discovery of genes that control the body's internal clock and regulate such processes as sleep, wakefulness and hunger signals. Research in the McKnight lab has recently shown mutations in a class of genes related to these "clock" functions have a broad range of outcomes, from abnormal eating and sleeping pa
'"/>

Contact: Megha Satyanarayana
megha.saty@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
29-Sep-2004


Page: 1 2

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. RSV can increase the risk of asthma, UT Southwestern researchers find
3. Searle Scholars program awards $240,000 to UT Southwestern researcher
4. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
5. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
6. UT Southwestern researchers reveal mechanisms of smooth-muscle contraction
7. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
8. UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders
9. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
10. UT Southwestern research halts narcolepsy symptoms
11. UT Southwestern researchers identify gene as essential for vascular smooth muscle development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... NEW YORK (PRWEB) , ... October 03, 2019 , ... ... the genome that cells hand down from one generation to the next. In a ... mutations can modulate the activity of this enzyme, leading to cancers and other diseases. ...
(Date:9/30/2019)... , ... September 30, 2019 , ... ... focused on increasing the capacity of life science organizations to accelerate innovation and ... Francisco, CA on October 4th. , What: Just 30 days to 21 CFR ...
(Date:9/25/2019)... ... September 25, 2019 , ... ... it ranked No. 3094 on Inc. Magazine’s annual Inc. 5000 list, the most ... growth of 120 percent. Based on this growth, the Houston-based firm also ranked ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... KITCHENER, Ontario (PRWEB) , ... October 02, 2019 ... ... protein sequencing using mass spectrometry, is pleased to announce that it has moved ... mass spectrometers among other analytical instruments, the new facility demonstrates the company's continuous ...
(Date:9/24/2019)... and WALTHAM, Mass. (PRWEB) , ... ... ... the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of ...
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, ... Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming ... on Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. ...
(Date:9/17/2019)... ... September 16, 2019 , ... ... CNBC on Saturday, September 21st @11:00am ET. Check local listings for more information ... (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to developing advanced ...
Breaking Biology Technology:
Cached News: